Oxford Asset Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Sell
1,312
-206
-14% -$42.8K 0.15% 199
2026
Q1
$321K Sell
1,518
-3,277
-68% -$706K 0.13% 241
2025
Q4
$985K Buy
+4,795
New +$902K 0.35% 66
2025
Q3
Sell
-10,919
Closed -$1.83M 482
2025
Q2
$1.83M Buy
+10,919
New +$1.62M 0.6% 20
2024
Q4
Sell
-9,192
Closed -$1.02M 469
2024
Q3
$1.02M Buy
+9,192
New +$961K 0.85% 12
2020
Q1
Sell
-195,551
Closed -$9.89M 384
2019
Q4
$9.89M Sell
195,551
-10,897
-5% -$563K 0.27% 70
2019
Q3
$9.74M Buy
206,448
+53,744
+35% +$2.45M 0.23% 93
2019
Q2
$7.19M Buy
+152,704
New +$7.04M 0.15% 155
2019
Q1
Sell
-68,217
Closed -$3.04M 1676
2018
Q4
$3.04M Buy
68,217
+48,615
+248% +$2.53M 0.08% 287
2018
Q3
$1.05M Sell
19,602
-182,744
-90% -$9.35M 0.02% 990
2018
Q2
$9.93M Buy
+202,346
New +$11.5M 0.19% 100

Other funds holding CAH

Oxford Asset Management's CAH Position: Q2 2026 in Review

Oxford Asset Management reduced its Cardinal Health (CAH) stake by 14% in Q2 2026, selling an estimated $42.8K and leaving 1,312 shares worth $312K. The position accounts for 0.15% of the portfolio, ranked #199.

Oxford Asset Management first reported a position in CAH in Q2 2018 and has held it in 11 quarters since. The position peaked at $9.93M in Q2 2018. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Oxford Asset Management held 1,312 shares of Cardinal Health worth $312K as of Q2 2026.
  • Oxford Asset Management sold 206 Cardinal Health shares in Q2 2026, an estimated $42.8K.
  • Cardinal Health made up 0.15% of Oxford Asset Management's portfolio in Q2 2026, its #199 holding.
  • Oxford Asset Management first reported a position in Cardinal Health in Q2 2018 and has held it in 11 quarters since.
  • Oxford Asset Management's Cardinal Health position peaked at $9.93M in Q2 2018.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.